13th Annual Conference on Statistical Issues in Clinical Trials: Cluster Randomized Clinical Trials (CRTs): Challenges and Opportunities

SPEAKERS AND TOPICS

View the Complete Conference Program

David Murray, (NIH)

"Overview: Innovations in the Design and Analysis of Group - or Cluster-Randomized Trials"

Victor DeGruttola, (Harvard)

"Using Network-level (and Individual-level) Information in Design and Analysis"

Luke J. Keele, (University of Pennsylvania)

"Complexities Caused by Noncompliance in Cluster Randomized Trials"

James P. Hughes, (University of Washington)

"Current Issues in the Design and Analysis of Stepped Wedge Trials"

Lawrence H. Moulton, (Johns Hopkins University)

"Randomization: Beyond the Closurization Principle"

Natalie E. Dean, (University of Florida)

"The Ring Trial Design for the Estimation of Vaccine Efficacy and Effectiveness During Infectious Disease Outbreaks"

Deborah J. Donnell, (University of Washington)

"Challenges in Implementing CRTs: from Hawthorne Effect to Measurement Bias"

Weile He, (AbbVie)

"Practical Considerations in Utilizing Cluster Randomization Trials in Medical Research"

PANELISTS

Karla Hemming, (University of Birmingham)
David Murray, (NIH)
Mike Proschan, (NIH)
Jeffrey Roberts, (FDA CBER)
Alisa J. Stephens-Shields, (University of Pennsylvania)
Monica Taljaard, (Ottawa Hospital Research Institute)